BioMedWire Stocks

More American Doctors are Relocating to Canada, Citing Federal Government Issues

As U.S. news outlets focus on the economic turmoil triggered by tariffs, another story is quietly developing. More doctors trained and working in the U.S. are relocating to Canada and the reasons they are giving rotate around the actions and policies of the Trump administration.

Michael, a pseudonym, is one such doctor who left the U.S. to work in Canada. He says America is changing into a country that steps on the vulnerable and weak, in contrast to the training which makes physicians kind to individuals during their weakest moments. For him, the turning point was when a mob stormed Capitol Hill in a bid to block Biden’s electoral victory from being certified. Michael was mortified by how quickly vigilantism was becoming an acceptable form of expression.

Michael packed his bags and moved his family to Canada during the first weeks of Trump’s current administration.

Michael isn’t the only American doctor who is disillusioned with what the U.S. society is becoming. Canada’s medical council revealed that physiciansapply.ca, a site which is the first point of contact for doctors wishing to obtain a license to practice in Canada, has seen a 750% bump in the number of American doctors applying in the past 7 months in comparison to the same time the previous year. In actual numbers, 615 U.S. doctors have expressed interest in 7 months compared to just 71 applications in the same duration last year.

Some specific steps taken by the Trump administration that may have rubbed doctors the wrong way include ignoring due process and disregarding court orders, major reductions to Medicaid funding, reallocating money that was originally earmarked for pandemic preparedness, demonizing fluoride, staff cuts to federal medical agencies, and the administration’s choice of Robert F. Kennedy, Jr. as HHS Secretary. RFK Jr. has controversial views on how people can preserve their health, and many doctors regard his views as pseudoscience.

It is important to note that Canada’s healthcare system provides universal care funded by the government. This is in contrast to the U.S. system which is largely privately funded and the government only funds Medicare and Medicaid for sections of the population. Many doctors in the U.S. complain about the heavy bureaucracy associated with the country’s system since it sometimes puts financial interests above the needs of patients.

Provinces in Canada are aware of the challenges facing the U.S. healthcare system, and some are actively advertising themselves as being free from those bottlenecks. For example, Doctors Manitoba, a group uniting doctors in Manitoba, kicked off a recruitment drive targeting physicians from America. It promises that there will be no political interference in the way doctors relate with their patients.

Over time, the extent to which doctors are leaving the U.S. and opting to work elsewhere, such as Canada, will become clearer. What hasn’t yet been examined is how this could affect the hospital networks that Medical Advantage plan providers like Astiva Health and other health insurance firms work with.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) AI Platform Brings Precision to Heart Health

At the core of Cardio Diagnostics’ approach is the use of artificial intelligence to integrate…

1 day ago

Survey Finds That American Adults Want Health Inequities Eliminated

Last fall, Johns Hopkins School of Nursing through its Institute for Policy Solutions conducted a survey on health inequities…

1 day ago

New Urine Test Could Predict Response to Bladder Cancer Treatment

Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has…

2 days ago

Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition

BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is…

3 days ago

Why Molecular Testing is Increasingly Important in CNS Cancers

Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity,…

4 days ago

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Broadens AI Intoxication Detection Platform with Launch of Intox Collect(TM)

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. The…

5 days ago